From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk

  • 0Faculty of Pharmacy, Integral University, Lucknow, UP, India. rufaidaw@iul.ac.in.

|

|

Summary

This summary is machine-generated.

Long COVID, a post-SARS-CoV-2 condition, causes persistent cardiovascular symptoms like arrhythmias and heart failure. Further research is needed to understand its cellular basis and identify predictive biomarkers.

Area Of Science

  • Cardiology
  • Infectious Diseases
  • Pathophysiology

Background

  • COVID-19 is a global epidemic with long-term, multi-organ effects, including cardiovascular complications.
  • Long COVID symptoms can persist for weeks or months post-SARS-CoV-2 infection, impacting various organ systems.
  • Common cardiovascular manifestations include electrocardiogram abnormalities, postural orthostatic tachycardia, and arrhythmias.

Purpose Of The Study

  • To investigate the cardiovascular and vascular implications of long COVID.
  • To explore potential mechanisms behind long COVID cardiovascular symptoms, including perimyocarditis and microthrombosis.
  • To assess the predictive value of current biomarkers for long COVID outcomes.

Main Methods

  • Utilized cardiac and vasculature imaging to identify cardiovascular changes.
  • Analyzed persistent perimyocarditis, ventricular dysfunction, arterial inflammation, and microthrombosis in affected patients.
  • Evaluated circulating coagulation and inflammatory markers at three months post-SARS-CoV-2 infection.

Main Results

  • Cardiac and vascular imaging revealed persistent post-infectious perimyocarditis, leading to potential ventricular failure, arterial inflammation, and microthrombosis.
  • Current biomarkers (coagulation, inflammatory markers) showed limited predictive value for long COVID existence or outcomes at three months.
  • The study highlights the need for deeper understanding of cellular and molecular processes driving long COVID.

Conclusions

  • Long COVID presents significant cardiovascular challenges, including potential heart failure and vascular damage.
  • Current biomarkers are insufficient for predicting long COVID cardiovascular complications.
  • Further research into the underlying pathophysiology and novel biomarkers is crucial for effective prevention and treatment strategies.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations 01:19

354

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Acute Coronary Syndrome I: Introduction 01:30

804

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Coronary Artery Disease II: Pathophysiology 01:26

367

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Artery Disease III: Clinical Manifestations 01:30

325

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

Cardiomyopathy VII: Pre and Post Operative Nursing Management 01:28

285

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

Coronary Artery Disease I: Introduction 01:30

878

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...